2015
DOI: 10.1097/mco.0000000000000133
|View full text |Cite
|
Sign up to set email alerts
|

Frailty and cognitive decline

Abstract: The present findings are suggestive of an almost complete lack of evidence on the addressed topic. In particular, randomized controlled trials are strongly needed in order to gain insights about the possibility of positively affecting the frailty syndrome by acting of cognition and improving cognitive impairment by targeting the physical components of frailty. Moreover, these studies may produce the first evidences about the novel concept of 'cognitive frailty' and its potential for reversibility.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
61
0
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 85 publications
(72 citation statements)
references
References 29 publications
2
61
0
3
Order By: Relevance
“…Furthermore, physical frailty predicts incident cognitive impairment (Canevelli et al, 2015). However, previous research yielded mixed results as to whether cognitive impairment had additional impact on disability for those who are already physically frail (Ament et al, 2014;Avila-Funes et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…Furthermore, physical frailty predicts incident cognitive impairment (Canevelli et al, 2015). However, previous research yielded mixed results as to whether cognitive impairment had additional impact on disability for those who are already physically frail (Ament et al, 2014;Avila-Funes et al, 2009).…”
Section: Discussionmentioning
confidence: 99%
“…25 Although we do not fully understand the mechanisms driving this association between frailty and cognition among adult KT recipients, recent reviews of frailty and cognition in older adults suggested potential effects of inflammation, cardiovascular disease, nutrition, and neuropathology. 23,24 Among KT recipients especially, consumption of immunosuppressive medications may potentially serve as a chronic stressor. As shown by prior research, frail recipients may not recover from the physiologic stress of their immunosuppressive regimens as efficiently as nonfrail recipients; in theory, their underlying multisystem dysfunction hinders their ability to reach homeostasis in the face of stressors introduced by such medications with dose-dependent adverse events, putting them at higher risk of poor KT outcomes.…”
Section: Discussionmentioning
confidence: 99%
“…27 In studies of older adults, frailty is associated with worse cognitive function. 23,24 The PFP has since been shown to be an important predictor of adverse outcomes in ESRD and KT populations. 29233 It occurs in approximately 20% of KT recipients of all ages, 34 and it has been identified as a key risk factor for poor health outcomes, including quality of life, delirium, delayed graft function, hospital length of stay, early hospital readmission, mycophenolate mofetil intolerance, and mortality.…”
mentioning
confidence: 99%
“…A review article examining the current evidence on the relation between frailty and cognition 13 found that the vast majority of the studies evaluated the frailty syndrome using the components defined by Fried et al 5 , since the objective was to analyze the physical dimension of the syndrome 13 . As for cognitive evaluation, the studies mainly used brief screening scales, such as the Mini-Mental State Examination (MMSE) 13 . These findings suggest the need to use more complex batteries for cognitive evaluation to determine the domains most altered by frailty.…”
Section: Introductionmentioning
confidence: 99%